Fu An Liu
Directeur Financier/CFO chez CONCORD MEDICAL CO., LTD.
Profil
Fu An Liu is currently holding two positions as Chief Financial & Accounting Officer & Director at Concord Medical Co., Ltd.
and as a Member-Supervisory Board at BioFirst Corp.
In the past, he worked as Chief Financial & Accounting Officer & IR Contact at Sagittarius Life Science Corp.
from 2004 to 2011.
Mr. Liu completed his undergraduate degree at National Chung Hsing University.
Postes actifs de Fu An Liu
Sociétés | Poste | Début |
---|---|---|
BIOFIRST CORP | Directeur/Membre du Conseil | 18/04/2014 |
CONCORD MEDICAL CO., LTD. | Directeur Financier/CFO | 06/08/2014 |
Anciens postes connus de Fu An Liu
Sociétés | Poste | Fin |
---|---|---|
SAGITTARIUS LIFE SCIENCE CORP | Directeur Financier/CFO | - |
Formation de Fu An Liu
National Chung Hsing University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SAGITTARIUS LIFE SCIENCE CORP | Health Technology |
CONCORD MEDICAL CO., LTD. | Distribution Services |
Entreprise privées | 1 |
---|---|
BioFirst Corp.
BioFirst Corp. BiotechnologyHealth Technology BioFirst Corp. engages in the research and development, manufacture and sale of medical equipment and medicines. Its products include testing equipment and reagents, vitreous filler, and Nano drug carriers. The company is the agent of Infopia's Clover AlcSelf glycosylated hemoglobin real time detection system, Infopia's GluKoPetA1c animal hemoglobin detection system, and BioPredictive's FibroTest and FibroMax liver fibrosis assessment tools. The company was founded on November 7, 2006 and is headquartered in Taipei, Taiwan. | Health Technology |